SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Dr. John M. de Castro who wrote (379)12/1/1998 8:49:00 AM
From: Jongmans  Read Replies (1) | Respond to of 4474
 
More information can be found on Rhone Poulenc Rorer's website:

rp-rorer.com

Have a look at the press-releases search!

best regards

Martin



To: Dr. John M. de Castro who wrote (379)12/18/1998 7:17:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 4474
 
CNBC just announced that they would be discussing a new approach to asthma (targeting Interleukins) and this morning the WSJ has an extensive article on asthma programs targeting IL-4, IL-5, and IL-13.
I have started a thread at:
biocognizance.com